VERASTEM INC's ticker is VSTM and the CUSIP is 92337C104. A total of 140 filers reported holding VERASTEM INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,563,000 | -29.4% | 5,369,029 | -3.6% | 0.03% | -26.8% |
| Q2 2022 | $6,463,000 | -1.0% | 5,571,633 | +20.4% | 0.04% | +24.2% |
| Q1 2022 | $6,527,000 | -28.2% | 4,629,353 | +5.4% | 0.03% | -17.5% |
| Q4 2021 | $9,093,000 | +86.0% | 4,393,080 | +176.8% | 0.04% | +81.8% |
| Q3 2021 | $4,888,000 | – | 1,587,230 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,865,000 | $3,823,000 | 1.61% |
| Altium Capital Management LP | 2,253,000 | $4,619,000 | 1.27% |
| BVF INC/IL | 17,062,158 | $34,977,000 | 1.27% |
| MPM BioImpact LLC | 3,271,532 | $6,707,000 | 1.22% |
| Opaleye Management Inc. | 2,325,000 | $4,766,000 | 1.01% |
| Soleus Capital Management, L.P. | 1,644,500 | $3,371,000 | 0.34% |
| Baker Brothers Advisors | 21,491,630 | $44,058,000 | 0.21% |
| Ikarian Capital, LLC | 637,371 | $1,308,000 | 0.20% |
| Samalin Investment Counsel, LLC | 90,000 | $185,000 | 0.11% |
| Parkman Healthcare Partners LLC | 183,332 | $376,000 | 0.08% |